首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1907935

核酸外切酶市場：依產品類型、酵素類型、原料、產品形式、反應特異性、應用、最終使用者和地區分類

Exonucleases Market, By Product Type, By Enzyme Type, By Source, By Product Format, By Reaction Specificity, By Application, By End User, By Geography

出版日期: 2025年12月11日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年，核酸外切酶市場價值將達到 1.842 億美元，到 2032 年將達到 3.261 億美元，2025 年至 2032 年的複合年成長率為 8.5%。

分析範圍		分析詳情
基準年	2024	市場規模（2025 年）	1.842億美元
效能數據	2020-2024	預測期	2025-2032
預測期（2025-2032 年）複合年成長率	8.50%	預計金額（2032 年）	3.261億美元

全球核酸外切酶市場是生物技術和生命科學產業的關鍵細分市場，其產品包括催化DNA和RNA分子末端磷酸二酯鍵水解的酵素。這些先進的分子工具在多種應用中發揮著至關重要的作用，例如PCR純化、DNA定序、克隆、基因工程和診斷檢測。核酸外切酶的分類依據包括其反應方向（3'至5'或5'至3'）、基材特異性（DNA或RNA）以及結構需求（單鏈或雙鏈特異性）。

此市場涵蓋多種酵素類型，例如核酸外切酶I、核酸外切酶III、T7核酸外切酶和λ核酸外切酶，每種酵素在分子生物學應用中都發揮不同的功能作用。隨著基因組學研究的快速發展、個人化醫療的進步以及生物技術的創新，對高品質核酸外切酶的需求正顯著成長。該市場服務於廣泛的終端用戶，包括學術研究機構、製藥公司、生物技術公司、診斷實驗室和受託研究機構。隨著精準醫療和基因療法的不斷發展，核酸外切酶已成為次世代定序工作流程、基於CRISPR的基因編輯系統以及先進治療應用開發中的關鍵組成部分，使該市場成為現代分子生物學基礎設施的基石。

市場動態

全球核酸外切酶市場受到許多強勁市場促進因素的推動，例如基因組研究舉措的空前擴張、政府對生物技術計劃的資助不斷增加，以及需要先進診斷解決方案的遺傳疾病日益普遍。個人化醫療方法的日益普及以及次世代定序應用的激增，正在科研和臨床領域催生對高性能核酸外切酶的巨大需求。

此外，CRISPR-Cas9基因編輯技術的廣泛應用以及腫瘤和罕見疾病領域中新型治療方法的開發，正顯著推動市場成長。然而，也存在著許多限制因素，例如酵素生產和純化過程的高成本、生物技術產品嚴格的監管要求，以及酵素處理和儲存方面的技術複雜性。

此外，能夠有效運用這些先進分子工具的專業人員數量有限，也為終端使用者帶來了操作上的挑戰。儘管有這些限制，合成生物學新應用的湧現、具有增強性能的耐熱和工程化核酸外切酶的開發，以及開發中國家生物技術基礎設施的擴展，都為市場創造了巨大的機會。人工智慧在藥物研發過程中的應用、對伴隨診斷日益成長的關注，以及實驗室工作流程自動化程度的不斷提高，都為市場擴張開闢了新的途徑。

此外，酵素生產商和製藥公司之間為開發新型治療應用而建立的策略聯盟，以及對專注於創新分子工具的生物技術Start-Ups公司加大投資，預計將釋放核酸外切酶市場領域的巨大成長潛力。

本報告的主要特點

本報告對全球核酸外切酶市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和復合年成長率。
它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
全球核酸外切酶市場的主要企業將根據以下參數進行分析，例如公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作關係、市場擴張和行銷策略做出明智的決策。
《全球核酸外切酶市場》報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球核酸外切酶市場的各種策略矩陣更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 南非
- 北非
- 中非

第12章競爭格局

New England Biolabs
Thermo Fisher Scientific
Promega Corporation
Agilent Technologies
Qiagen
Takara Bio
Merck KGaA（Sigma-Aldrich）
F. Hoffmann-La Roche
Bio-Rad Laboratories
Illumina
Becton Dickinson
Enzymatics
Lucigen
Zymo Research
GenScript

第13章分析師建議

機會
分析師觀點
Coherent Opportunity Map (COM)

第14章參考文獻與分析方法

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI9057

Exonucleases Market is estimated to be valued at USD 184.2 Mn in 2025 and is expected to reach USD 326.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 184.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.50%	2032 Value Projection:	USD 326.1 Mn

The global exonucleases market represents a critical segment within the biotechnology and life sciences industry, encompassing enzymes that catalyze the hydrolysis of phosphodiester bonds at the terminal ends of DNA and RNA molecules. These sophisticated molecular tools play an indispensable role in various applications including PCR cleanup, DNA sequencing, cloning, genetic engineering, and diagnostic assays. Exonucleases are classified based on their directional activity (3' to 5' or 5' to 3'), substrate specificity (DNA or RNA), and structural requirements (single-strand or double-strand specificity).

The market encompasses various enzyme types including Exonuclease I, Exonuclease III, T7 Exonuclease, and Lambda Exonuclease, each serving distinct functional purposes in molecular biology applications. With the exponential growth of genomics research, personalized medicine initiatives, and biotechnology innovations, the demand for high-quality exonucleases has witnessed substantial acceleration. The market serves diverse end users including academic research institutions, pharmaceutical companies, biotechnology firms, diagnostic laboratories, and contract research organizations. As precision medicine and gene therapy continue to evolve, exonucleases have become fundamental components in developing next-generation sequencing workflows, CRISPR-based gene editing systems, and advanced therapeutic applications, positioning this market as a cornerstone of modern molecular biology infrastructure.

Market Dynamics

The global exonucleases market is propelled by robust drivers including the unprecedented expansion of genomics research initiatives, increasing government funding for biotechnology projects, and the rising prevalence of genetic disorders necessitating advanced diagnostic solutions. The growing adoption of personalized medicine approaches, coupled with the surge in next-generation sequencing applications, has created substantial demand for high-performance exonucleases in research and clinical settings.

Furthermore, the proliferation of CRISPR-Cas9 gene editing technologies and the development of novel therapeutic approaches in oncology and rare diseases are significantly driving market growth. However, the market faces notable restraints including the high costs associated with enzyme production and purification processes, stringent regulatory requirements for biotechnology products, and the technical complexity involved in enzyme handling and storage requirements.

Additionally, the limited availability of skilled professionals capable of effectively utilizing these sophisticated molecular tools poses operational challenges for end-users. Despite these constraints, the market presents exceptional opportunities driven by emerging applications in synthetic biology, the development of thermostable and engineered exonucleases with enhanced performance characteristics, and the expanding biotechnology infrastructure in developing economies. The integration of artificial intelligence in drug discovery processes, increasing focus on companion diagnostics, and the growing trend toward automation in laboratory workflows are creating new avenues for market expansion.

Moreover, strategic collaborations between enzyme manufacturers and pharmaceutical companies for developing novel therapeutic applications, along with the rising investment in biotechnology startups focused on innovative molecular tools, are expected to unlock significant growth potential in the exonucleases market landscape.

Key Features of the Study

This report provides in-depth analysis of the global exonucleases market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global exonucleases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include New England Biolabs, Thermo Fisher Scientific, Promega Corporation, Agilent Technologies, Qiagen, Takara Bio, Merck KGaA (Sigma-Aldrich), F. Hoffmann-La Roche, Bio-Rad Laboratories, Illumina, Becton Dickinson, Enzymatics, Lucigen, Zymo Research, and GenScript
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global exonucleases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exonucleases market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Single-stranded exonucleases
- Double-stranded exonucleases
Enzyme Type Insights (Revenue, USD Mn, 2020 - 2032)
- 5 3 Exonucleases
- 3 5 Exonucleases
- Dual-Activity Exonucleases
- Proofreading Exonucleases
- Mismatch Repair Exonucleases
- Restriction-Associated Exonucleases
Source Insights (Revenue, USD Mn, 2020 - 2032)
- Prokaryotic Exonucleases
- Eukaryotic Exonucleases
- Viral Exonucleases
- Recombinant/Synthetic Exonucleases
Product Format Insights (Revenue, USD Mn, 2020 - 2032)
- Reagents and Kits
- Instruments and Systems
Reaction Specificity Insights (Revenue, USD Mn, 2020 - 2032)
- DNA-Specific Exonucleases
- RNA-Specific Exonucleases
- DNase/RNase Dual-Specific Exonucleases
Application Insights (Revenue, USD Mn, 2020 - 2032)
- PCR Cleanup
- DNA Sequencing Workflows
- RNA Sequencing Workflows
- Cloning and Molecular Cloning Workflows
- Genome Editing Protocols (CRISPR, TALEN, ZFN)
- DNA Repair and Mismatch Repair Studies
- Protein-Nucleic Acid Interaction Studies
- Diagnostic Assays
- Biopharmaceutical R and D Workflows
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Academic and Research Institutes
- Biotechnology Companies
- Pharmaceutical Companies
- Clinical and Diagnostic Laboratories
- Contract Research Organizations (CROs)
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- New England Biolabs
- Thermo Fisher Scientific
- Promega Corporation
- Agilent Technologies
- Qiagen
- Takara Bio
- Merck KGaA (Sigma-Aldrich)
- F. Hoffmann-La Roche
- Bio-Rad Laboratories
- Illumina
- Becton Dickinson
- Enzymatics
- Lucigen
- Zymo Research
- GenScript

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Exonucleases Market, By Product Type
- Global Exonucleases Market, By Enzyme Type
- Global Exonucleases Market, By Source
- Global Exonucleases Market, By Product Format
- Global Exonucleases Market, By Reaction Specificity
- Global Exonucleases Market, By Application
- Global Exonucleases Market, By End User
- Global Exonucleases Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Exonucleases Market, By Product Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Single-stranded exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Double-stranded exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Exonucleases Market, By Enzyme Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
5 3 Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
3 5 Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Dual-Activity Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Proofreading Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mismatch Repair Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Restriction-Associated Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Exonucleases Market, By Source, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Prokaryotic Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Eukaryotic Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Viral Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Recombinant/Synthetic Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Exonucleases Market, By Product Format, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Instruments and Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Exonucleases Market, By Reaction Specificity, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
DNA-Specific Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
RNA-Specific Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
DNase/RNase Dual-Specific Exonucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Exonucleases Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
PCR Cleanup
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
DNA Sequencing Workflows
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
RNA Sequencing Workflows
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cloning and Molecular Cloning Workflows
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Genome Editing Protocols (CRISPR, TALEN, ZFN)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
DNA Repair and Mismatch Repair Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Protein-Nucleic Acid Interaction Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diagnostic Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Biopharmaceutical R and D Workflows
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Exonucleases Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

11. Global Exonucleases Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Enzyme Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Reaction Specificity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Enzyme Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Reaction Specificity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Enzyme Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Reaction Specificity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Enzyme Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Reaction Specificity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Enzyme Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Reaction Specificity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Enzyme Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Reaction Specificity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

New England Biolabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qiagen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA (Sigma-Aldrich)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton Dickinson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Enzymatics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lucigen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zymo Research
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenScript
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies